CareRx Net Receivables from 2010 to 2025

CRRX Stock  CAD 2.75  0.02  0.73%   
CareRx Corp Net Receivables yearly trend continues to be very stable with very little volatility. Net Receivables is likely to drop to about 22.8 M. During the period from 2010 to 2025, CareRx Corp Net Receivables quarterly data regression pattern had sample variance of 291.9 T and median of  32,429,000. View All Fundamentals
 
Net Receivables  
First Reported
2002-12-31
Previous Quarter
29.2 M
Current Value
32.4 M
Quarterly Volatility
19.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CareRx Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CareRx Corp's main balance sheet or income statement drivers, such as Interest Expense of 10.5 M, Selling General Administrative of 29.1 M or Other Operating Expenses of 439 M, as well as many indicators such as Price To Sales Ratio of 0.65, Dividend Yield of 0.0 or PTB Ratio of 1.4. CareRx financial statements analysis is a perfect complement when working with CareRx Corp Valuation or Volatility modules.
  
This module can also supplement various CareRx Corp Technical models . Check out the analysis of CareRx Corp Correlation against competitors.

Other Information on Investing in CareRx Stock

CareRx Corp financial ratios help investors to determine whether CareRx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx Corp security.